X. Wang, “Stocks Valuation of Johnson & Johnson (J&J): Analysis of Ongoing Risks of Pharmaceuticals Corporations in Post-Pandemic Era”, HBEM, vol. 1, pp. 36–40, Nov. 2022, doi: 10.54097/hbem.v1i.2315.